Amaç: Hepatit C virüsü (HCV) enfeksiyonu, genellikle asemptomatik enfeksiyon oluşturmasına rağmen %85'lere varan kronikleşme oranı, karaciğer sirozu ve hepatoselüler karsinomunun en önemli sebeplerinden olması, etkin bir aşısının olmaması nedeni ile önemli bir halk sağlığı sorunudur. Genotiplerin belirlenmesi HCV'nin epidemiyolojik verilerin toplanmasında, antiviral tedavinin şekillendirilmesinde ve prognozunun ön görülmesinde önem taşımaktadır. Hastanemiz farklı uyruktan hastaların sıkça başvurduğu oldukça geniş bir bölgeye hizmet etmektedir. Bu çalışmada, hastanemizde HCV ile enfekte Türk ve yabancı uyruklu hastalarda HCV genotip farklılıklarının ve bu durumun yıllara göre dağılımının belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Retrospektif, tek merkezli gözlemsel olan bu çalışmada Ocak 2012-Aralık 2019 tarihleri arasında HCV RNA'sı pozitif, genotiplendirmesi yapılmış hastalar değerlendirmeye alındı. Hastaların demografik özellikleri, başvuru tarihleri, ırk ve HCV genotipleri hastane bilgi sistemi üzerinden bulunarak kaydedildi. Bulgular: Ocak 2012-Aralık 2019 tarihleri arasında HCV RNA'sı >1.000 IU/mL olan 413 hasta değerlendirilmeye alındı. Hastaların %51,33'ü erkek, ortalama yaş 54,38±16,28 yıldı. Genel genotip dağılımı incelendiğinde ilk sırada genotip (GT)1'in %78,69, ardından GT3 ve GT2, GT4 gelmektedir. Sonuç: Yabancılara tedavi verilememesi ve sığınmacıların kontrolünün sağlanamaması durumunda gelecek yıllarda HCV genotiplerin epidemiyolojinin değişebileceğini düşünmekteyiz.
Anahtar Kelimeler: HCV; genotip; sığınmacılar
Objective: Although hepatitis C virüs (HCV) infection is usually asymptomatic, it is an important public health problem because of its chronicity rate up to 85%, liver cirrhosis and hepatocellular carcinoma being the most important causes and lack of an effective vaccine. It is important to collect epidemiological data of HCV, to determine the genotype in planning antiviral therapy and to determine prognosis. Our hospital serves a wide area where patients from different nationalities frequently apply. The aim of this study was to determine HCV genotype differences and the distribution of HCV genotypes in Turkish and foreign patients infected with HCV in our hospital. Material and Methods: In this retrospective, singlecenter observational study, patients with positive HCV RNA and genotyping were evaluated. The demographic characteristics, admission dates, race and HCV genotypes of the patients were determined through the hospital information system. Results: Between January 2012-December 2019, 413 patients with HCV RNA> 1.000 IU/mL were included in the study. While 51.33% of the patients were male, the average age was 54.38±16.28 years, When the general genotype distribution was examined, it was found that genotype (GT)1 was 78.69%, followed by GT3, GT2 and GT4. Conclusion: However, we think that the epidemiology of HCV genotypes may change in the coming years if treatment is not provided to foreigners and the control of immigrant is not achieved.
Keywords: HCV; genotypes; immigrants
- Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558-67. [Crossref]
- Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-41. [Crossref] [PubMed] [PMC]
- Ghany MG, Strader DB, Thomas DL, Seff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335-74. [Crossref] [PubMed]
- World Health Organization (WHO). Global Hepatitis Report 2017. Geneva: WHO; 2017. p.62. http://www. who.int/hepatitis/publications/global-hepatitis-report2017/en/.
- Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-73. [Crossref] [PubMed]
- Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther. 2005;10(1):1-11.
- Kayman T, Karakükçü Ç, Karaman A, Gözütok F. [Genotypic distribution of hepatitis C virus infection in Kayseri region]. Türk Mikrobiyol Cem Derg. 2012;42(1):21-6.
- Tezcan S, Ulger M, Aslan G, Yaraş S, Altıntaş E, Sezgin O, et al. [Determination of hepatitis C virus genotype distribution in Mersin province, Turkey]. Mikrobiyol Bul. 2013;47(2):332-8. [Crossref] [PubMed]
- Aktaş O, Özbek A, Aydın H, Özkülekci MB. Distribution of HCV genotypes in patients of with chronic hepatitis C in the Eastern Anatolia region. Viral Hepatitis Journal. 2014;20:91-4. [Crossref]
- Saglik İ, Mutlu D, Öngut G, İnan D, Öğünç D, Can Sarinoğlu R, et al. [Distribution of hepatitis C virus genotypes among patients with chronic hepatitis C infection in Akdeniz University Hospital, Antalya, Turkey: a fiveyear evaluation]. Mikrobiyol Bul. 2014;48(3):429-37. [Crossref] [PubMed]
- Kirdar S, Aydin N, Tiryaki Y, Ertugrul B, Coskun A, Bilgen M. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factors. APMIS. 2018;126(2):109-13. [Crossref] [PubMed]
- Us T, Kasifoglu N, Aslan FG, Aslan M, Akgun Y, Durmaz G. The distribution of hepatitis C virus genotypes of patients with chronic hepatitis C infection in the Eskisehir Region of Turkey. J Clin Anal Med. 2016;1:1-4. [Crossref]
- Selek MB, Baylan O, Karagöz E, Özyurt M. Changes in hepatitis C virus genotype distribution in chronic hepatitis C infection patients. Indian J Med Microbiol. 2018;36(3):416-21. [Crossref] [PubMed]
- Karabulut N, Alacam S, Yolcu A, Onel M, Agacfidan A. Distribution of hepatitis C virus genotypes in Istanbul, Turkey. Indian J Med Microbiol. 2018;36(2):192-6. [Crossref] [PubMed]
- Buruk CK, Bayramoğlu G, Reis A, Kaklıkkaya N, Tosun I, Aydın F. [Determination of hepatitis C virus genotypes among hepatitis C patients in Eastern Black Sea Region, Turkey]. Mikrobiyol Bul. 2013;47(4):650-7. [Crossref] [PubMed]
- Karslıgil T, Savaş E, Savaş MC. [Genotype distribution and 5'UTR nucleotide changes in hepatitis C virus]. Balkan Med J. 2011;28:232-6.
- Öztürk AB, Doğan ÜB, Öztürk NA, Özyazıcı G, Demir M, Akın MS, et al. Hepatitis C virus genotypes in Adana and Antakya regions of Turkey. Turk J Med Sci. 2014;44(4):661-5. [Crossref] [PubMed]
- Caliskan A, Kirisci O, Ozkaya E, Ozden S, Tumer S, Caglar S, et al. Distribution and predominance of genotype 3 in hepatitis C virus carriers in the province of Kahramanmaras, Turkey. Hepat Mon. 2015;15(4):e25142. [Crossref]
- Altuğlu I, Sertöz R, Aksoy A, Gürsel D, Tüzüner U, Günşar F. Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey. Turk J Gastroenterol. 2013;24(4):349-55. [Crossref] [PubMed]
- Tüzüner U, Saran Gülcen B, Özdemir M, Feyzioğlu B, Baykan M. Seven-year genotype distribution among hepatitis C patients in a city in the Central Anatolia Region of Turkey. Viral Hepatitis Journal. 2018;24(1):12-7. [Crossref]
- Duran AÇ, Kibar F, Çetiner S, Yaman A. [Determination of hepatitis C virus genotype and HCV infection transmission routes in Cukurova University Medical Faculty Hospital]. Turk Hij Den Biyol Derg. 2017;74(3):201-10. [Crossref]
- Memon MI, Memon MA. Hepatitis C: an epidemiological rewiew. J Vital Hepat. 2002;9(2):84-100. [Crossref] [PubMed]
- Petruzziello A, Marigliano S, Loquercio G, Cacciapuoti C. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infect Agent Cancer. 2016;11:53. [Crossref] [PubMed] [PMC]
- Robaeys G, Bielen R, Azar DG, Razavi H, Nevens F. Global genotype distribution of hepatitis C viral infection among people who inject drugs. J Hepatol. 2016;65(6):1094-103. [Crossref] [PubMed]
- Cirit OS, Uzala Mızraklı A, Vurupalmaz Y, Gümüş HH, Özturhan H, Barış A. Genotyping distribution of hepatitis C virus in Şanlıurfa province and effect of Syrian patients. Viral Hepat J. 2019;25(2):62-6. [Crossref]
- Welzel TM, Bhardwaj N, Hedskog C, Chodavarapu K, Camus G, McNally J, et al. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. J Hepatol. 2017;67(2):224-36. [Crossref] [PubMed]
- Kartashev V, Döring M, Nieto L, Coletta E, Kaiser R, Sierra S, et al. New findings in HCV genotype distribution in selected West European, Russian and Israeli regions. J Clin Virol. 2016;81:82-9. [Crossref] [PubMed]
- Çekin Y, Gür N, Çekin AH, Altuğlu İ, Yazan Sertöz R. [Investigation of HCV genotype distribution in patient in patients with chronic hepatitis C infections in Antalya Training and Research Hospital, Turkey]. Mikrobiyol Bul. 2014;48(3):484-90. [Crossref] [PubMed]
- Borcak D, Çağır Ü, Yalçıner A. Distribution of hepatitis C virüs genotypes and their association with serum alanine aminotransferases and quantitive serum HCV RNA levels. Ankem Derg. 2015;29:36-40. [Crossref]
- Çizmeci Z. [The distribution of hepatitis C virus genotypes in patients with chronic hepatitis c infection]. Türk Mikrobiyol Cem Derg. 2016;46(1):27-32. [Crossref]
- Kaya S, Afşar İ, Aksoy Gökmen A, Şener AG, Sayıner A. Evaluation of hepatitis C virus genotype results in İzmir Atatürk Training and Research Hospital. Viral Hepat J. 2019;25(2):59-61. [Crossref]
- Backus LI, Belperio PS, Shahoumian TA, Mole LA. Impact of sustained virologic response with direct-acting antiviral treatment on mor tality in patients with advanced liver disease. Hepatology. 2019;69(2):487-97. [Crossref] [PubMed]
.: Process List